In the present study, we aimed to evaluate whether exposure to metalloestrogens commonly present in everyday human life, aluminum and chromium (III), may reduce the effectiveness of aromatase inhibitors used in hormone therapy of breast cancer. Here, CYP19A1 is linked to breast carcinoma.